Skip to main content
SpringerLink
Log in

Pharmakologische Streßechokardiographie mit Dobutamin, Dipyridamol und Arbutamin: Praktische Durchführung

  • Chapter
Book cover Streßechokardiographie

  • 26 Accesses

Zusammenfassung

Die Anmeldung erfolgt mit einem speziell für die Dobutamin-Echokardiographie entworfenen Untersuchungsprotokoll (Abb. 10.1), das von den betreuenden Stationsärzten ausgefüllt wird. Die stichwortartige Zusammenfassung der Anamnese, der aktuellen Beschwerden und Indikationsstellung sowie der Ergebnisse der vorausgegangenen kardiologischen Untersuchungen (z.B. Ergometrie, Myokardszintigraphie, Koronarangiographie etc.) in dem ersten Teil des Untersuchungsprotokolls erweist sich unserer Erfahrung nach für den Untersucher als sehr hilfreich, damit er sich während der Untersuchung besonders auf spezielle Fragestellungen konzentrieren, aber auch frühzeitig auf mögliche Komplikationen achten kann. Sie ermöglicht außerdem, das Ergebnis der Untersuchung in den gesamten klinischen Rahmen zu stellen und damit weitere Entscheidungen für diagnostische bzw. therapeutische Maßnahmen individuell zu treffen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 10.1

  1. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA (1995) Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91: 663–670.

    Article  PubMed  CAS  Google Scholar 

  2. Akosah KO, Porter TR, Simon R, Funai JT, Minisi AJ, Mohanty PK (1993) Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography. J Am Coll Cardiol 21: 584–5893.

    Article  PubMed  CAS  Google Scholar 

  3. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S (1991) Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 122: 1522–1531.

    Article  PubMed  CAS  Google Scholar 

  4. Berthe C, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J, Kulbertus HE (1986) Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 58: 1167–1172.

    Article  PubMed  CAS  Google Scholar 

  5. Boccanelli A, Piazza V, Greco C, Zanchi E, Cecchetti C, Pontillo D, Pellada JJ, Risa A, Baragli D, Prati PL (1993) Dobutamine stress echocardiography in the diagnosis of coronary artery disease. Gior ital di cardiol 23:19–28.

    CAS  Google Scholar 

  6. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA (1993) Dobutamine Stress Echocardiography Identifies Hibernating Myocardium and Predicts Recovery of Left Ventricular Function After Coronary Revascularization. Circulation 88: 430–436.

    Article  PubMed  CAS  Google Scholar 

  7. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS (1991) Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 67: 1311–1318.

    Article  PubMed  CAS  Google Scholar 

  8. Epstein M, Gin K, Sterns L, Pollick C (1992) Dobutamine echocardiography: initial experience of a Canadian center. Can J Cardiol 8: 273–279.

    PubMed  CAS  Google Scholar 

  9. Erbel R, Schweitzer P, Lambert H, Henn G, Meyer J, Krebs W, Effert S (1983) Echoventriculography—a simultaneous analysis of two dimensional echocardiography and cineventriculography. Circulation 67: 205–215.

    Article  PubMed  CAS  Google Scholar 

  10. Frank E (1956) An accurate clinically practical system for spatial vectorcardiography. Circulation 13: 737.

    Article  PubMed  CAS  Google Scholar 

  11. Haque T, Furukawa T, Takahashi M, Kinoshita M (1995) Indentification of hibernating myocardium by dobutamine stress echocardiography: Comparation with thallium-201 reinjection imaging. Am Heart J 130: 553–563.

    Article  PubMed  CAS  Google Scholar 

  12. Heinecker R (1980) EKG in Praxis und Klinik. Thieme Stuttgart, New York. S 40.

    Google Scholar 

  13. Lalka SG, Sawada SG, Dalsing MC, Cikrit DF, Sawchuk AP, Kovacs RL, Segar DS, Ryan T, Feigenbaum H (1992) Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 15:831–840.

    Article  PubMed  CAS  Google Scholar 

  14. Lemmerz AH (1970) Atlas des EKG nach Frank. Karger, Basel.

    Google Scholar 

  15. Marcovitz PA, Armtrong WF (1992) Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 69: 1269–1273.

    Article  PubMed  CAS  Google Scholar 

  16. Marcovitz PA, Armtrong WF (1991) Dobutamine stress echocardiography: diagnostic utility. Herz 16: 372–378.

    PubMed  CAS  Google Scholar 

  17. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, Gimelli A, L’abbate A (1993) Value of rest thallium-201/technetium 99 m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 71: 166–172.

    Article  PubMed  CAS  Google Scholar 

  18. Mazeika P, Nadazdin A, Oakley CM (1992) Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 19: 1203–1211.

    Article  PubMed  CAS  Google Scholar 

  19. McNeill AJ, Fioretti PM, El.Said SM, Salustri A, Forster T, Roelandt JR (1992) Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 70: 41–46.

    Article  PubMed  CAS  Google Scholar 

  20. McNeill AJ, Fioretti PM, El.Said SM, Salustri A, de-Peyter PJ, Roelandt JR (1992) Dobutamine stress echocardiography before and after angioplasty. Am J Cardiol 69: 740–745.

    Article  PubMed  CAS  Google Scholar 

  21. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H (1993) Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 88: 15–19.

    Article  PubMed  CAS  Google Scholar 

  22. Nesto RW, Kowalchuck GJ (1987) The ischemic cascade: Temporal sequence of haemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 57: 23C–27C.

    Article  Google Scholar 

  23. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ (1995) Stress Echocardiography. Part II. Dobutamine Stress Echocardiography: Techniques, Implementation, Clinical Applications, and Correlations. Mayo Clin Proc 70: 16–27.

    PubMed  CAS  Google Scholar 

  24. Pierard LA, Berthe C, Albert A, Calier J, Kulbertus HE (1989) Haemodynamic alterations during ischemia induced by dobutamine stress testing. Eur Heart J 10: 783–790.

    PubMed  CAS  Google Scholar 

  25. Pierard LA, De-Landsheere CM, Berthe C, Rigo P, Kulbertus HE (1990) Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 15: 1021–1031.

    Article  PubMed  CAS  Google Scholar 

  26. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH, Arnese M, Roelandt JR (1994) Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 73: 456–459.

    Article  PubMed  CAS  Google Scholar 

  27. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrano M (1993) Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 72: 124G–130G.

    Article  PubMed  CAS  Google Scholar 

  28. Rosamond TL, Vacek JL, Hurwitz A, Rowland AJ, Beauchamp GD, Crouse LJ (1992) Hypotension during dobutamine stress echocardiography: initial description and clinical relevance. Am Heart J 123: 403–407.

    Article  PubMed  CAS  Google Scholar 

  29. Salustri A, Fioretti PM, Pozzoli MM, McNeil AJ, Roelandt JR (1992) Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J 13: 70–77.

    PubMed  CAS  Google Scholar 

  30. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, Fineberg NS, Armstrong WF, Feigenbaum H (1991) Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83: 1605–1614.

    Article  PubMed  CAS  Google Scholar 

  31. Schröder K, Völler H, Hansen B, Levenson B, Wilkenshoff U, Schröder R (1992) Streß-Echokardiographie als Routine-Untersuchung bei koronarer Herzkrankheit. Dtsch med Wschr 117: 1583–1588.

    Article  PubMed  Google Scholar 

  32. Schwendel V (1989) Technische und methodische Grundlagen der Elektrokardiographie. In: Csapo G, Kalutsche D (Hrsg) Konventionelle und intrakardiale Elektrokardiographie. Ciba-Geigy. S 50.

    Google Scholar 

  33. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H (1992) Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 19: 1197–1202.

    Article  PubMed  CAS  Google Scholar 

  34. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkowitz K, Bourdillon PDV, Feigenbaum H (1993) Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 88: 405–415.

    Article  PubMed  CAS  Google Scholar 

  35. Smart SC (1994) The clinical utility of echocardiography in the assessment of myocardial viability. J Nucl Med 35(Suppl): 49S–58S.

    PubMed  CAS  Google Scholar 

  36. Upton MT, Rerych SK, Newman GE, Port S, Cobb FR, Jones RH (1980) Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation 62: 341–349.

    Article  PubMed  CAS  Google Scholar 

  37. Voci P, Bilotta F, Caretta Q, Mercanti C, Marino B (1995) Low-dose dobutamine echocardiography predicts the early response of dysfunctioning myocardial segments to coronary artery bypass grafting. Am Heart J 129: 521–526.

    Article  PubMed  CAS  Google Scholar 

  38. Zahn R, Lotter R, Nöhl H, Schiele R, Bergmeier C, Zander M, Seidl K, Senges J (1996) Praktikabilität und Sicherheit der Dobutamin-Streßechokardiographie: Erfahrungen bei 1000 Untersuchungen. Z Kardiol 85: 27–34.

    Google Scholar 

Literatur zu Kapitel 10.2

  1. Kadatz R (1959) Die pharmakologischen Eigenschaften der neuen coronarerweiternden Substanz 2,6-Bis(dia-ethanolamino)-4,8-dipiperidino-pyrimido(5,4-d)pyrimidin. Arzn Forsch 9: 39–45.

    CAS  Google Scholar 

  2. Lattanzi F, Picano E, Bolognese L, Piccinino C, Sarasso G, Orlandini A, L’abbate A (1991) Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 83: 1256–1262.

    Article  PubMed  CAS  Google Scholar 

  3. Mazeika P, Nihoyannopoulos P, Joshi J, Oakley CM (1992) Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart J 67: 144–149.

    Article  PubMed  CAS  Google Scholar 

  4. Nesto RW, Kowalchuck GJ (1987) The ischemic cascade: Temporal sequence of haemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 57: 23C–27C.

    Article  Google Scholar 

  5. Osterspey A, Jansen W, Weldin S, Tauchert M, Hilger HH (1982) Medikamentöse Beeinflußbarkeit des Dipy-ridamol-Tests. Therapiew 32: 3533.

    Google Scholar 

  6. Osterspey A, Jansen W, Tauchert M, Eigl J, Höpp H, Behrenbeck DW, Hilger HH (1983) Stellenwert des Dipyridamol-Tests in der Diagnostik der koronaren Herzkrankheit. Dtsch med Wschr 108: 1469–1475.

    Article  PubMed  CAS  Google Scholar 

  7. Picano E, Lattanzi F, Masini M, Distante A, L’abbate A (1988) Aminophylline termination of dipyridamole stress as a trigger of coronary vasospasm in variant angina. Am J Cardiol 62: 694–697.

    Article  PubMed  CAS  Google Scholar 

  8. Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L’abbate A (1985) Dipyridamole echocardiography test in effort angina pectoris. Am J Cardiol 56: 452–456.

    Article  PubMed  CAS  Google Scholar 

  9. Picano E, Lattanzi F, Masini M, Distante A, L’abbate A (1986) High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 8: 848–854.

    Article  PubMed  CAS  Google Scholar 

  10. Picano E (1989) Dipyridamole echocardiography test: historical background and physiologic basis. Eur Heart J 10: 365–376.

    PubMed  CAS  Google Scholar 

  11. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti G, Chiarella F, Orlandini A, Seveso G, Colosso MQ, Sciavo MG, Magaia O, Agati L, Previtali M, Lowenstein J, Torre F, Rosselli P, Ciuti M, Ostojic M, Gandolfo N, Margaria F, Giannuzzi P, DiBello V, Lombardi M, Gigli G, Ferrara N, Santoro F, Lusa AM, Chiaranda G, Papagna D, Coletta C, Boccardi L, De Cristofaro M, Papi L, Landi P and the Echo-Persantine International cooperative study group (1992) Safety of intravenous high dose dipyridamole echocardiography. Am J Cardiol 70: 252–258.

    Article  PubMed  CAS  Google Scholar 

  12. Picano E, Pingitore A, Conti U, Kozakova M, Boem A, Cabani E, Distante A, L’abbate A (1993) Enhanced sensitivity for the detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 14: 1216–1222.

    Article  PubMed  CAS  Google Scholar 

  13. Spitzbarth H (1959) Kreislaufanalytische und klinische Studien über 2,6-Bis(diaethanolamino)-4,8-dipi-peridino-pyrimido(5,4d)pyrimidin. Arzn Forsch 9: 59–61.

    CAS  Google Scholar 

  14. Tauchert M (1977) Der Dipyridamol-Test als Suchmethode bei koronarer Herzkrankheit. Internist 18: 588–593.

    PubMed  CAS  Google Scholar 

  15. Upton MT, Rerych SK, Newman GE, Port S, Cobb FR, Jones RH (1980) Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation 62: 341–349.

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kapitel 10.3

  1. Young M, Pan W, Wiesner J, Bullough D, Brown G, Balow G, Patter S, Metzner K, Mullane K (1994) Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Develop Res 32: 19–28.

    Article  CAS  Google Scholar 

  2. Dennis CA, Pool PE, Perrius EJ, Mohinddin SM, Sklar J, Kostuk WJ, Muller DWM, Starling MR 1995 for the International Arbutamine Study Group. Stress testing with closed-loop arbutamine as an alternative to exercise. J Am Coll Cardiol 26: 1151–1158.

    Article  PubMed  CAS  Google Scholar 

  3. Kiat H, Iskandrian AS, Villegas BJ, Starling MR, Berman DS 1995 for the International Arbutamine Study Group. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. J Am Coll Cardiol 26: 1159–1167.

    Article  PubMed  CAS  Google Scholar 

  4. Cohen JL, Chan KL, Jaarsma W, Bach DS, Muller DWM, Starling MR, Armstrong WF 1995 for the International Arbutamine Study Group. Arbutamine echocardiography: Efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. J Am Coll Cardiol 26: 1168–1175.

    Article  PubMed  CAS  Google Scholar 

  5. Marwick T (1995) Arbutamine stress testing with closed-loop drug delivery. Towards the ideal or just another pharmacologic stress technique. J Am Coll Cardiol 26: 1178–1179.

    Google Scholar 

  6. Nixdorff U, Mertes H, Erbel R, Baker T, Hillman R, Steiner J, Wölfinger D, Meyer J (1990) Arbutamine—A new pharmacologic stress test for coronary heart disease. Initial experience. Transesophageal—Intraluminal—Stress Echocardiography. New Views to the Heart. International Symposium (Mainz-Mayo-Symposium), Mainz (Germany), 31.10.-2.11.1990.

    Google Scholar 

  7. Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly S, Wölfinger D, Meyer J (1991) Belastungsechokardiographie: Eine sensitive Methode in der Diagnostik der koronaren Herzkrankheit. Herz 16: 355–366.

    PubMed  CAS  Google Scholar 

  8. Gorge G, Erbel R, Brennecke R, Rupprecht HJ, Todt M, Meyer J (1992) High-resolution two-dimensional echocardiography improves the quantification of left ventricular function. J Am Soc Echocardiogr 5: 125–134.

    PubMed  CAS  Google Scholar 

  9. Picano E, Lattanzi F, Orlandini A, Martini C, L’abbate A (1991) Stress echocardiography and the human factor. The importance of being expert. J Am Coll Cardiol 17: 666–669.

    Article  PubMed  CAS  Google Scholar 

  10. Fioretti PM, Poldermans D, Salustri A, Forster T, Bellotti P, Boersma E, McNeill AJ. el Said ES. Roe-landt JR (1994) Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 15: 355–360.

    Article  PubMed  CAS  Google Scholar 

  11. Wagner S, Mohr-Kahaly S, Nixdorff U, Kölsch B, Menzel T, Wittlich N, Meinert R, Meyer J (1996) Prospektive Untersuchung zur subjektiven Beeinträchtigung durch die Dobutaminbelastungsechokardiographie-Auswirkungen auf die diagnostische Sicherheit. Z Kardiol 85: 588–595.

    PubMed  CAS  Google Scholar 

  12. Cramer M-JM, Jaarsma W, Sutherland GR, Nihoyannopoulos P, Fioretti P, Tan LB, Schröder K, Visser CA, on behalf of the European Arbutamine Study Group (1995) Safety and efficacy of computerized closed-loop delivery of arbutamine: A new pharmacologic myocardial stress modality for the assessment of coronary artery disease. J Am Soc Echocardiogr 8: 854–863.

    Article  PubMed  CAS  Google Scholar 

  13. Blevius RD. Whitty AJ, Rubenfire M, Maciejko JJ (1989) Dopamine and dobutamine induced hypokalemia in anesthetized dogs. J Cardiovasc Pharmacol 13: 662–666.

    Google Scholar 

  14. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H (1993) Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88: 15–19.

    Article  PubMed  CAS  Google Scholar 

  15. Ismail G, Sada M, Conant R, Shapiro S, Cao T, French W, Ginzton L (1992) Quantitative stress echocardiography: Comparison of exercise and pharmacologic stress with arbutamine. Circulation 86(Suppl): I–127.

    Google Scholar 

  16. Ismail G, Sada M, Conant R, Shapiro S, Cao T, French W (1992) Arbutamin. A new pharmacologie stress agent: Initial echocardiography experience. Clinres 40: 120A.

    Google Scholar 

  17. Bach DS, Armstrong WF, for the International Arbutamine Study Group (1995) Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography. Am J Cardiol 76: 259–262.

    Article  PubMed  CAS  Google Scholar 

  18. Hoffmann R, Lethen H, Kleinhaus E, Weiss M, Flachskampf F, Hanrath P (1993) Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease. Am J Cardiol 72: 555–559.

    Article  PubMed  CAS  Google Scholar 

  19. Rose GA, Weismann N, Foster GP, Picard MH (1995) Comparison of arbutamine to dobutamine stress echocardiography in humans. Circulation 92(Suppl 1): I–412.

    Google Scholar 

  20. Guth B, Mullane K (1994) Comparison of exercise and catecholamine stress agents in producing myocardial ischemia. J Am Coll Cardiol 25: 15A.

    Google Scholar 

  21. Hammond HK, McKirnan MD (1994) Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J Am Coll Cardiol 23: 475–482.

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kapitel 10.4

  1. Agati L, Renzi M, Sciomer S et al (1992) Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. J Am Coll Cardiol 19: 765–770.

    Article  PubMed  CAS  Google Scholar 

  2. Armstrong WF (1991) Stress echocardiography for detection of coronary artery disease. Circulation 84(Suppl I): 43–49.

    Google Scholar 

  3. Baer FM, Voth E, Deutsch H, Schneider CA, Schicha H, Sechtem U (1994) Assessment of viable myocardium by dobutamine-transesophageal-echocardiography (TEE) and comparison with FDG-PET. J Am Coll Cardiol 24:343–353.

    Article  PubMed  CAS  Google Scholar 

  4. Baer FM, Voth E, Deutsch H et al (1996) Predictive value of low-dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for the recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 28: 60–69.

    Article  PubMed  CAS  Google Scholar 

  5. Baer FM, Voth E, LaRosee K et al (1996) Comparison of dobutamine-transesophageal echocardiography and dobutamine-magnetic resonance imaging for the detection of residual myocardial viability. Am J Cardiol im Druck.

    Google Scholar 

  6. Chapman PD, Doyle TP, Troup PJ, Gross CM, Wann LS (1984) Stress echocardiography with transesophageal pacing: preliminary report of a new method for detection of ischemic wall motion abnormalities. Circulation 70: 445–450.

    Article  PubMed  CAS  Google Scholar 

  7. Ciggaroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA (1993) Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88: 430–436.

    Article  Google Scholar 

  8. Deutsch HJ, Curtius JM, Leischik R et al (1993) Reproducibility of left-ventricular function using intraoperative transesophageal echocardiography. Thorac Cardiovasc Surgeon 41: 54–58.

    Article  CAS  Google Scholar 

  9. Hoffmann R, Kleinhans E, Lambertz H, Flachskampf FA, Uebis R, Buell U, Hanrath P (1994) Transesophageal pacing echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty. Eur Heart J 15: 823–831.

    PubMed  CAS  Google Scholar 

  10. Lambertz H, Kreis A, Trümper H, Hanrath P (1990) Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography. A new method of stress echocardiography. J Am Coll Cardiol 16: 1143–1153.

    Article  PubMed  CAS  Google Scholar 

  11. Lang RM, Vignon P, Weinert L et al (1996) Echocardiographic quantitation of regional left ventricular wall motion with color kinesis. Circulation 93: 1877–1885.

    Article  PubMed  CAS  Google Scholar 

  12. Marwick TH, Willemart B, D’Hondt AM, Baudhuin T, Wijns W, Detry JM, Melin J (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Circulation 87: 345–354.

    Article  PubMed  CAS  Google Scholar 

  13. Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE (1992) Accuracy and limitations of exercise echocardiography in a routine clinical practice. J Am Coll Cardiol 19: 74–81.

    Article  PubMed  CAS  Google Scholar 

  14. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT (1995) Relation between thallium uptake and contractile response to dobutamine. Circulation 91: 990–998.

    Article  PubMed  CAS  Google Scholar 

  15. Panza JA, Laurienzo JM, Curiel RV, Quyyumi AA, Cannon RO (1994) Transesophageal dobutamine stress echocardiography for evaluation of patients with coronar artery disease. J Am Coll Cardiol 24: 1260–1267.

    Article  PubMed  CAS  Google Scholar 

  16. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE (1990) Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with PET. J Am Coll Cardiol 15: 1021–1031.

    Article  PubMed  CAS  Google Scholar 

  17. Prince CR, Stoddard MF. Morris GT, Ammash NM, Goad JL, Dawkins PR, Vogel RL (1994) Dobutamine two-dimensional transesophageal echocardiographic stress testing for detection of coronary artery disease. Am Heart 1:36–41.

    Article  Google Scholar 

  18. Seward JB, Khandkeria BK, Oh JK et al (1988) Transesophageal echocardiography: techniques, anatomic correlations, implementation and clinical applications. Mayo Clin Proc 63: 649–680.

    Article  PubMed  CAS  Google Scholar 

  19. Sutherland GR, Stewart MJ, Groundstroem KWE et al (1994) Color doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 7: 441–458.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leitender Arzt der Rehabilitationsklinik Hochstaufen der BfA — AHB-Klinik—, Herkommerstraße 2, 83455, Bayerisch, Germany

    Dr. med. Günter Haug (Internist — Kardiologie — Sportmedizin Rehabilitationswesen — Sozialmedizin)

Authors
  1. Dr. med. Günter Haug
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rehabilitationsklinik Hochstaufen der BfA — AHB-Klinik —, Herkommerstraße 2, 83455, Bayerisch Gmain, Germany

    Günter Haug (Internist — Kardiologie — Sportmedizin Rehabilitationswesen — Sozialmedizin, Leitender Arzt) (Internist — Kardiologie — Sportmedizin Rehabilitationswesen — Sozialmedizin, Leitender Arzt)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Haug, G. (1998). Pharmakologische Streßechokardiographie mit Dobutamin, Dipyridamol und Arbutamin: Praktische Durchführung. In: Haug, G. (eds) Streßechokardiographie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-59002-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59002-3_10

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63819-0

  • Online ISBN: 978-3-642-59002-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation